驱动器突变的性是预测克隆性血液形成转变风险的关键因素
Ashwin Kishtagari1,2, M A Wasay Khan3, Yajing Li4
1Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Blood cancer journal
|January 15, 2024
概括
克隆性血液形成 (CH) 的风险随着同时发生的突变和染色体改变而增加. 评估突变致死性对于预测血液性恶性瘤转变风险至关重要.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 克隆性血液形成 (CH) 增加了血液性恶性瘤的风险.
- 冠状病毒是由基因突变或染色体改变引起的.
- 目前对CH转化风险的预测是有限的.
研究的目的:
- 调查同时发生的CH突变和马赛克染色体变异 (mCA) 的预后影响.
- 确定同一位点的组合遗传事件是否会影响恶性瘤转变风险.
主要方法:
- 使用英国生物库 (n=451,180) 进行发现,使用BioVU (n=91,335) 进行验证.
- 分析了CHIP突变 (例如JAK2) 和mCA (例如9p CN-LOH) 的同时发生情况.
- 与遗传特征相关的血液恶性瘤发生率评估.
主要成果:
- 具有并发性体突变和mCA的个体显著增加了血液性恶性瘤风险.
- 在BioVU中,同时出现的JAK2 V617F和9p CN-LOH显著增加了风险 (HR=54.76,P<0.001).
- 突变致死性不是常规报告,但影响风险.
结论:
- 在同一位置同时出现CHIP和mCA是血液恶性瘤的重要危险因素.
- 建议对CHIP突变的临床报告.
- 未来的预测模型应该纳入突变的复合性,以提高准确性.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Mutations
82.4K
Overview
82.4K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Multiple Allele Traits
34.2K
The Concept of Multiple Allelism
34.2K


